Intra-Cellular Therapies Inc (ITCI)
85.29
+1.29
(+1.54%)
USD |
NASDAQ |
Dec 24, 13:00
85.29
0.00 (0.00%)
After-Hours: 13:15
Intra-Cellular Therapies Profit Margin (Quarterly): -15.03% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -10.58% |
| Return on Assets | -8.93% |
| Return on Invested Capital | -10.58% |
| Gross Profit Margin (Quarterly) | 91.26% |
| Operating Margin (Quarterly) | -22.18% |
| Return on Net Operating Assets | -52.09% |